Company Name: WAVE Life Sciences Ltd.  

WAVE Life Sciences Ltd. is a preclinical biopharmaceutical company. The company is engaged in the development of stereopure nucleic acid therapeutic candidates using its proprietary synthetic chemistry drug development platform.  The company’s most advanced programs target:

  • Duchenne muscular dystrophy
  • Huntington’s disease
  • Inflammatory bowel disease

Ticker Symbol: WVE (NASDAQ)

Company Website:

Social Media:

Wave Life Sciences LinkedIn

Wave Life Sciences Twitter

Headquarters: Singapore; Cambridge, MA